science
plus
.abes.fr
|
explorer
À propos de :
HIV/AIDS
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
skos:Concept
, within Data Space :
scienceplus.abes.fr
associated with source
document(s)
Type:
Concept
New Facet based on Instances of this Class
Attributs
Valeurs
type
Concept
rdfs:label
HIV/AIDS
HIV/Aids
Hiv/Aids
skos:inScheme
http://hub.abes.fr/referentiel/ouparticlecategories
is
Subject
of
Prolonged Suppression of Human Immunodeficiency Virus Type 1 RNA during Dual Nucleoside Reverse-Transcriptase-Inhibitor Therapy in Clinical Practice
Substitution of a Nonnucleoside Reverse Transcriptase Inhibitor for a Protease Inhibitor in the Treatment of Patients with Undetectable Plasma Human Immunodeficiency Virus Type 1 RNA
Value of Mandatory Testing for Human Immunodeficiency Virus in a Sub-Saharan Hospital Population
Osteonecrosis Complicating Highly Active Antiretroviral Therapy in Patients Infected with Human Immunodeficiency Virus
Failure of Combination Therapy with Lamivudine and Famciclovir following Lamivudine Monotherapy for Hepatitis B Virus Infection in Patients Coinfected with Human Immunodeficiency Virus-1
A Randomized Study of the Utility of Human Immunodeficiency Virus RNA Measurement for the Management of Antiretroviral Therapy
Evolution of Antifungal Susceptibility among Candida Species Isolates Recovered from Human Immunodeficiency Virus—Infected Women Receiving Fluconazole Prophylaxis
Antiretroviral Therapy Adherence and Viral Suppression in HIV-Infected Drug Users: Comparison of Self-Report and Electronic Monitoring
Focal Neurological Disease in Patients with Acquired Immunodeficiency Syndrome
A Controlled Trial of Itraconazole as Primary Prophylaxis for Systemic Fungal Infections in Patients with Advanced Human Immunodeficiency Virus Infection in Thailand
Response to Lamivudine-Zidovudine plus Abacavir Twice Daily in Antiretroviral-Naive, Incarcerated Patients with HIV Infection Taking Directly Observed Treatment
Severe Nucleoside-Associated Lactic Acidosis in Human Immunodeficiency Virus-Infected Patients: Report of 12 Cases and Review of the Literature
Directly Observed Therapy for the Treatment of People with Human Immunodeficiency Virus Infection: A Work in Progress
Absence of Opioid Withdrawal Symptoms in Patients Receiving Methadone and the Protease Inhibitor Lopinavir-Ritonavir
Topical Microbicides for Disease Prevention: Status and Challenges
Viral Coinfections among African Children Infected with Human Immunodeficiency Virus Type 1
Clinical and Immunologic Outcome in Patients with Human Immunodeficiency Virus Infection, According to Virologic Efficacy in the Year after Virus Undetectability, during Antiretroviral Therapy
Effect of Prenatal Vitamin Supplementation on Lower-Genital Levels of HIV Type 1 and Interleukin Type 1β at 36 Weeks of Gestation
Single-Slice Computed Tomography and Anthropometric Skinfold Analysis for Evaluation of Facial Lipoatrophy in HIV-Infected Patients
Antiretroviral Drug Pharmacokinetics in Hepatitis with Hepatic Dysfunction
Subclinical Tuberculosis in HIV-Infected Patients: Another Challenge for the Diagnosis of Tuberculosis in High-Burden Countries?
Resistance to Dual Nucleoside Reverse-Transcriptase Inhibitors in Children Infected with HIV Clade A/E
Influence of Liver Fibrosis on Highly Active Antiretroviral Therapy—Associated Hepatotoxicity in Patients with HIV and Hepatitis C Virus Coinfection
A Molecular Epidemiological Analysis of 2 Staphylococcus aureus Clonal Types Colonizing and Infecting Patients with AIDS
The Role of Immune Reconstitution Inflammatory Syndrome in AIDS-Related Cryptococcus neoformans Disease in the Era of Highly Active Antiretroviral Therapy
Avascular Necrosis in HIV-Infected Patients: A Case-Control Study from the Aquitaine Cohort, 1997-2002, France
Accuracy, Precision, and Consistency of Expert HIV Type 1 Genotype Interpretation: An International Comparison (The GUESS Study)
The Clinical Pharmacokinetics of Rifampin and Ethambutol in HIV-Infected Persons with Tuberculosis
Superiority of Protease Inhibitors over Nonnucleoside Reverse-Transcriptase Inhibitors when Highly Active Antiretroviral Therapy Is Resumed after Treatment Interruption
A Randomized Trial of Directly Administered Antiretroviral Therapy and Adherence Case Management Intervention
A Comparison of Miltefosine and Sodium Stibogluconate for Treatment of Visceral Leishmaniasis in an Ethiopian Population with High Prevalence of HIV Infection
Efficacy and Safety of Atazanavir-Based Highly Active Antiretroviral Therapy in Patients with Virologic Suppression Switched from a Stable, Boosted or Unboosted Protease Inhibitor Treatment Regimen: The SWAN Study (AI424-097) 48-Week Results
Impact of Maternal HIV Coinfection on the Vertical Transmission of Hepatitis C Virus: A Meta-analysis
Factors Associated with the Incidence of Type 2 Diabetes Mellitus in HIV-Infected Participants in the Swiss HIV Cohort Study
Nucleoside Reverse-Transcriptase Inhibitor Dosing Errors in an Outpatient HIV Clinic in the Electronic Medical Record Era
Coinfection with HIV and Tropical Infectious Diseases. II. Helminthic, Fungal, Bacterial, and Viral Pathogens
Long-Term Effects of Highly Active Antiretroviral Therapy on CD4+ Cell Evolution among Children and Adolescents Infected with HIV: 5 Years and Counting
Extremely High Prevalence and Genetic Diversity of Hepatitis C Virus Infection among HIV-Infected Injection Drug Users in Taiwan
Walking the Tightrope in Prevention of Mother-to-Child Transmission of HIV Infection
Nutritional Status of Persons with HIV Infection, Persons with HIV Infection and Tuberculosis, and HIV-Negative Individuals from Southern India
Association between Vγ2Vδ2 T Cells and Disease Progression after Infection with Closely Related Strains of HIV in China
Hepatitis Virus Coinfection in the Strategic Management of Antiretroviral Therapy (SMART) Study: A Marker for Nonliver, Non-Opportunistic Disease Mortality
Antiretroviral Therapy Is Associated with Reduced Serologic Failure Rates for Syphilis among HIV-Infected Patients
Treatment of Kaposi Sarcoma in the Highly Active Antiretroviral Therapy Era
Anticardiolipin Antibodies in HIV Infection Are Independently Associated with Antibodies to the Membrane Proximal External Region of gp41 and with Cell-Associated HIV DNA and Immune Activation
A Randomized Trial Comparing Plasma Drug Concentrations and Efficacies between 2 Nonnucleoside Reverse-Transcriptase Inhibitor-Based Regimens in HIV-Infected Patients Receiving Rifampicin: The N2R Study
Lymphoma Diagnosis and Plasma Epstein-Barr Virus Load during Vicriviroc Therapy: Results of the AIDS Clinical Trials Group A5211
Effect of HIV-1 Subtype on Virologic and Immunologic Response to Starting Highly Active Antiretroviral Therapy
Treatment Responses in Antiretroviral Treatment-Naive Premenopausal and Postmenopausal HIV-1-Infected Women: An Analysis from AIDS Clinical Trials Group Studies
Dried Blood Spots Perform Well in Viral Load Monitoring of Patients Who Receive Antiretroviral Treatment in Rural Tanzania
Spontaneous Control of Viral Replication during Primary HIV Infection: When Is “HIV Controller” Status Established?
Uncontrolled HIV RNA, Immunodeficiency, and Malignancy: Implications for Cancer Control
HIV-Associated Tuberculosis: Clinical Update
Retaining HIV-Infected Patients in Care: Where Are We? Where Do We Go from Here?
How Do HIV Elite Controllers Do What They Do?
Ocular Syphilis among HIV-Infected Individuals
Antiretroviral Prescribing Patterns in the Texas Prison System
Occurrence of Acute Hepatitis A in Patients Infected with Human Immunodeficiency Virus
Effect of Highly Active Antiretroviral Therapy on the Serological Response to Additional Measles Vaccinations in Human Immunodeficiency Virus-Infected Children
Clinical Indicators of Immune Restoration following Highly Active Antiretroviral Therapy
The Consistency of Adherence to Antiretroviral Therapy Predicts Biologic Outcomes for Human Immunodeficiency Virus—Infected Persons in Clinical Trials
Assessing Eosinophil Count as a Marker of Immune Activation among Human Immunodeficiency Virus—Infected Persons in Sub-Saharan Africa
Multifocal Vasculopathy Due to Varicella-Zoster Virus (VZV): Serial Analysis of VZV DNA and Intrathecal Synthesis of VZV Antibody in Cerebrospinal Fluid
Serious Bradyarrhythmia That Was Possibly Induced by Lopinavir-Ritonavir in 2 Patients with Acquired Immunodeficiency Syndrome
Decrease in Human Immunodeficiency Virus Type 1 Load during Acute Dengue Fever
Factors Associated with Maintenance of Long-Term Plasma Human Immunodeficiency Virus RNA Suppression
Long-Term Efficacy, Safety, and Tolerability of Indinavir-Based Therapy in Protease Inhibitor—Naive Adults with Advanced HIV Infection
A Prospective, Randomized Trial Examining the Efficacy and Safety of Clarithromycin in Combination with Ethambutol, Rifabutin, or Both for the Treatment of Disseminated Mycobacterium avium Complex Disease in Persons with Acquired Immunodeficiency Syndrome
HIV Infection behind Bars
Increase in Sexual Risk Behavior Associated with Immunologic Response to Highly Active Antiretroviral Therapy among HIV-Infected Injection Drug Users
Pulmonary Arterial Hypertension Related to HIV Infection: Improved Hemodynamics and Survival Associated with Antiretroviral Therapy
What Drives Hepatitis B Virus-Related Hepatic Flares? Virus, T Cells—Or a Bit of Both?
Incidence of and Risk Factors for Adverse Drug Reactions in a Prospective Cohort of HIV-Infected Adults Initiating Protease Inhibitor—Containing Therapy
Changes in Weight and Lean Body Mass during Highly Active Antiretroviral Therapy
Safety and Immunogenicity of an Inactivated Hepatitis A Vaccine among HIV-Infected Subjects
Antimicrobial Prophylaxis in Children with HIV Infection
Risk Factors for Community-Associated Methicillin-Resistant Staphylococcus aureus Skin Infections among HIV-Positive Men Who Have Sex with Men
Mother-to-Child Transmission of HIV Infection in the Era of Highly Active Antiretroviral Therapy
Bacterial Diarrhea in HIV-Infected Patients: Why Clostridium difficile, and Why Now?
Community Permission for Medical Research in Developing Countries
Immunogenicity and Tolerability of Hepatitis A Vaccine in HIV-Infected Children
Treatment of Chronic Hepatitis B in HIV-Infected Persons: Thinking Outside the Black Box
The Relationship between Nucleoside Analogue Treatment Duration, Insulin Resistance, and Fasting Arterialized Lactate Level in Patients with HIV Infection
Models for Integrating Buprenorphine Therapy into the Primary HIV Care Setting
Effect of Maintaining Highly Active Antiretroviral Therapy on AIDS Events among Patients with Late-Stage HIV Infection and Inadequate Response to Therapy
Long-Term Effects of Highly Active Antiretroviral Therapy in Pretreated, Vertically HIV Type 1-Infected Children: 6 Years of Follow-Up
Longitudinal Analysis of Clinical Markers following Antiretroviral Therapy Initiated during Acute or Early HIV Type 1 Infection
Psychotropic Medications and HIV
Which Policy to ADAP-T: Waiting Lists or Waiting Lines?
Plasma Nevirapine Levels and 24-Week Efficacy in HIV-Infected Patients Receiving Nevirapine-Based Highly Active Antiretroviral Therapy with or without Rifampicin
Management of Herpes Simplex Virus Type 2 Infection in HIV Type 1-Infected Persons
Symptomatic Relapse of Neurologic Syphilis after Benzathine Penicillin G Therapy for Primary or Secondary Syphilis in HIV-Infected Patients
Monoclonal Gammopathy Associated with HIV Infection
Influence of Human T Cell Lymphotropic Virus Type 2 Coinfection on Virological and Immunological Parameters in HIV Type 1-Infected Patients
Use of Peripheral Blood DNA for Genotype Antiretroviral Resistance Testing in Drug-Naive HIV-Infected Subjects
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 19
Go
Alternative Linked Data Documents:
ODE
Content Formats:
RDF
ODATA
Microdata